Cargando…

Increased CSF levels of total Tau in patients with subcortical cerebrovascular pathology and cognitive impairment

Cognitive impairment includes mild cognitive decline and dementia, such as Alzheimer's disease (AD) and cerebrovascular-related pathologies. OBJECTIVE: To investigate the profile of AD-related CSF biomarkers in a sample of cognitively impaired and unimpaired older adults with concomitant subcor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Radanovic, Márcia, Stella, Florindo, Silva, Lis Gomes, Talib, Leda L., Forlenza, Orestes V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Associação de Neurologia Cognitiva e do Comportamento 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5770001/ https://www.ncbi.nlm.nih.gov/pubmed/29354223 http://dx.doi.org/10.1590/1980-57642016dn11-040012

Ejemplares similares

Correlation between CSF biomarkers of Alzheimer’s disease and global cognition in a psychogeriatric clinic cohort
por: Radanovic, Márcia, et al.
Publicado: (2019)

Decision tree-based classification as a support to diagnosis in the Alzheimer’s disease continuum using cerebrospinal fluid biomarkers: insights from automated analysis
por: Costa, Alana, et al.
Publicado: (2022)

Electroconvulsive therapy for treating patients with agitation and related behavioral disorders due to dementia: a systematic review
por: Stella, Florindo, et al.
Publicado: (2023)

Early diagnosis and treatment of Alzheimer’s disease: new definitions and challenges
por: Pais, Marcos, et al.
Publicado: (2020)

Cerebrospinal fluid biomarkers in Alzheimer's disease: Diagnostic accuracy and prediction of dementia
por: Forlenza, Orestes V., et al.
Publicado: (2015)

Revisiting global cognitive and functional state 13 years after a clinical trial of lithium for mild cognitive impairment
por: Damiano, Rodolfo Furlan, et al.
Publicado: (2023)

Impact of SARS-CoV-2 pandemic on mental health in the elderly: perspective from a psychogeriatric clinic at a tertiary hospital in São Paulo, Brazil
por: Forlenza, Orestes V., et al.
Publicado: (2020)

New treatment strategies for Alzheimer's disease: is there a hope?
por: Aprahamian, Ivan, et al.
Publicado: (2013)

Discourse abilities in euthymic elderly patients with bipolar disorder: a preliminary study
por: Valeriano, Maria Gabriela, et al.
Publicado: (2023)

Textual Inference Comprehension in Mild Cognitive Impairment: The Influence of Semantic Processing and Verbal Episodic Memory
por: Maziero, Maria Paula, et al.
Publicado: (2021)

Mood disorders in the elderly: prevalence, functional impact, and management challenges
por: Valiengo, Leandro da Costa Lane, et al.
Publicado: (2016)

Nonpharmacological Interventions to Reduce Behavioral and Psychological Symptoms of Dementia: A Systematic Review
por: de Oliveira, Alexandra Martini, et al.
Publicado: (2015)

CSF tau368/total-tau ratio reflects cognitive performance and neocortical tau better compared to p-tau181 and p-tau217 in cognitively impaired individuals
por: Simrén, Joel, et al.
Publicado: (2022)

Attenuated CSF‐1R signalling drives cerebrovascular pathology
por: Delaney, Conor, et al.
Publicado: (2020)

CSF tau and β-amyloid as biomarkers for mild cognitive impairment
por: Hampel, Harald, et al.
Publicado: (2004)

Cerebrovascular Senescence Is Associated With Tau Pathology in Alzheimer's Disease
por: Bryant, Annie G., et al.
Publicado: (2020)

Cerebrovascular disease promotes tau pathology in Alzheimer’s disease
por: Laing, Krystal K, et al.
Publicado: (2020)

Cognitive training in older adults with Mild Cognitive Impairment: Impact on cognitive and functional performance
por: Brum, Paula Schimidt, et al.
Publicado: (2009)

CSF p-tau as a potential cognition impairment biomarker in ALS
por: Gong, Zhongying, et al.
Publicado: (2022)

Cognitive impairment: an (in)dependent risk factor for mortality in older men?
por: Loureiro, Júlia C., et al.
Publicado: (2020)

Combining Cognitive Screening Tests for the Evaluation of Mild Cognitive Impairment in the Elderly
por: Ladeira, Rodolfo B., et al.
Publicado: (2009)

CSF MTBR-tau243 is a specific biomarker of tau tangle pathology in Alzheimer’s disease
por: Horie, Kanta, et al.
Publicado: (2023)

Medical cannabinoids for treatment of neuropsychiatric symptoms in dementia: a systematic review
por: Stella, Florindo, et al.
Publicado: (2021)

Neurobiological pathways to Alzheimer’s disease: Amyloid-beta, TAU protein or both?
por: de Paula, Vanessa de Jesus R., et al.
Publicado: (2009)

Levels of Cortisol in CSF Are Associated With SNAP-25 and Tau Pathology but Not Amyloid-β
por: Wang, Qing, et al.
Publicado: (2018)

CSF tau microtubule-binding region identifies pathological changes in primary tauopathies
por: Horie, Kanta, et al.
Publicado: (2022)

CSF total tau levels are associated with hippocampal novelty irrespective of hippocampal volume
por: Düzel, Emrah, et al.
Publicado: (2018)

CSF tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and tau pathology in Alzheimer’s disease
por: Barthélemy, Nicolas R., et al.
Publicado: (2023)

CSF total tau/α-synuclein ratio improved the diagnostic performance for Alzheimer’s disease as an indicator of tau phosphorylation
por: Shim, Kyu Hwan, et al.
Publicado: (2020)

Whole‐brain DTI parameters associated with tau protein and hippocampal volume in Alzheimer's disease
por: Magalhães, Thamires Naela Cardoso, et al.
Publicado: (2023)

Elevated CSF GAP-43 is Alzheimer’s disease specific and associated with tau and amyloid pathology
por: Sandelius, Åsa, et al.
Publicado: (2018)

Annexin A1 restores cerebrovascular integrity concomitant with reduced amyloid-β and tau pathology
por: Ries, Miriam, et al.
Publicado: (2021)

Plasma tau complements CSF tau and P-tau in the diagnosis of Alzheimer's disease
por: Fossati, Silvia, et al.
Publicado: (2019)

CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease
por: Janelidze, Shorena, et al.
Publicado: (2018)

Cognitive and structural cerebral changes in amnestic mild cognitive impairment due to Alzheimer's disease after multicomponent training
por: Teixeira, Camila Vieira Ligo, et al.
Publicado: (2018)

One-carbon metabolism, cognitive impairment and CSF measures of Alzheimer pathology: homocysteine and beyond
por: Dayon, Loïc, et al.
Publicado: (2017)

Long-Term Lithium Treatment Increases cPLA(2) and iPLA(2) Activity in Cultured Cortical and Hippocampal Neurons
por: De-Paula, Vanessa de Jesus, et al.
Publicado: (2015)

Screening for cognitive impairment in late onset depression in a Brazilian sample using the BBRC-Edu
por: Novaretti, Tânia Maria da Silva, et al.
Publicado: (2012)

Hearing impairment is associated with cognitive decline, brain atrophy and tau pathology
por: Wang, Hui-Fu, et al.
Publicado: (2022)

Contribution of Tau Pathology to Mitochondrial Impairment in Neurodegeneration
por: Pérez, María J., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_n6576qu0bp9qcgallp24a9sc5j